MAPT and Alzheimer disease: AD is characterized by progressive loss of memory, thinking, learning, and cognitive ability, aggregation (including extracellular deposition) of the Aβ peptide, and intracellular aggregation of phosphorylated tau protein (Kim-Ha and Kim, 2016).